Tudor Oprea
Tudor Oprea
Professor and Chief, Translational Informatics Division, UNM School
Verified email at salud.unm.edu - Homepage
Title
Cited by
Cited by
Year
Is There a Difference Between Leads and Drugs? A Historical Perspective.
TI Oprea, AM Davis, SJ Teague, PD Leeson
Journal of chemical information and computer sciences 41 (5), 1308-1315, 2001
8562001
The design of leadlike combinatorial libraries
SJ Teague, AM Davis, PD Leeson, T Oprea
Angewandte Chemie International Edition 38 (24), 3743-3748, 1999
7401999
Virtual and biomolecular screening converge on a selective agonist for GPR30
CG Bologa, CM Revankar, SM Young, BS Edwards, JB Arterburn, ...
Nature chemical biology 2 (4), 207-212, 2006
7222006
A comprehensive map of molecular drug targets
R Santos, O Ursu, A Gaulton, AP Bento, RS Donadi, CG Bologa, ...
Nature reviews Drug discovery 16 (1), 19, 2017
6812017
Estrogen signaling through the transmembrane G protein–coupled receptor GPR30
ER Prossnitz, JB Arterburn, HO Smith, TI Oprea, LA Sklar, HJ Hathaway
Annu. Rev. Physiol. 70, 165-190, 2008
5982008
Property distribution of drug-related chemical databases
TI Oprea
Journal of computer-aided molecular design 14 (3), 251-264, 2000
5622000
Pursuing the leadlikeness concept in pharmaceutical research
MM Hann, TI Oprea
Current opinion in chemical biology 8 (3), 255-263, 2004
5132004
Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system
E Brailoiu, SL Dun, GC Brailoiu, K Mizuo, LA Sklar, TI Oprea, ER Prossnitz, ...
Journal of endocrinology 193 (2), 311-321, 2007
4422007
In vivo effects of a GPR30 antagonist
MK Dennis, R Burai, C Ramesh, WK Petrie, SN Alcon, TK Nayak, ...
Nature chemical biology 5 (6), 421, 2009
4412009
G protein–coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells
L Albanito, A Madeo, R Lappano, A Vivacqua, V Rago, A Carpino, ...
Cancer research 67 (4), 1859-1866, 2007
4232007
BDDCS applied to over 900 drugs
LZ Benet, F Broccatelli, TI Oprea
The AAPS journal 13 (4), 519-547, 2011
4222011
Chemography: the art of navigating in chemical space
TI Oprea, J Gottfries
Journal of combinatorial chemistry 3 (2), 157-166, 2001
3202001
Integrating virtual screening in lead discovery
TI Oprea, H Matter
Current opinion in chemical biology 8 (4), 349-358, 2004
3082004
VALIDATE: A new method for the receptor-based prediction of binding affinities of novel ligands
RD Head, ML Smythe, TI Oprea, CL Waller, SM Green, GR Marshall
Journal of the American Chemical society 118 (16), 3959-3969, 1996
3041996
Current trends in lead discovery: Are we looking at the appropriate property
TI Oprea
Journal of computer-aided molecular design 16 (5-6), 325-334, 2002
277*2002
Novel chemical space exploration via natural products
J Rosén, J Gottfries, S Muresan, A Backlund, TI Oprea
Journal of medicinal chemistry 52 (7), 1953-1962, 2009
2412009
Flow cytometry for high-throughput, high-content screening
BS Edwards, T Oprea, ER Prossnitz, LA Sklar
Current opinion in chemical biology 8 (4), 392-398, 2004
2322004
Ligand-based identification of environmental estrogens
CL Waller, TI Oprea, K Chae, HK Park, KS Korach, SC Laws, TE Wiese, ...
Chemical research in toxicology 9 (8), 1240-1248, 1996
2321996
The G protein–coupled receptor GPR30 inhibits proliferation of estrogen receptor–positive breast cancer cells
EA Ariazi, E Brailoiu, S Yerrum, HA Shupp, MJ Slifker, HE Cunliffe, ...
Cancer research 70 (3), 1184-1194, 2010
2212010
Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity
MK Dennis, AS Field, R Burai, C Ramesh, WK Petrie, CG Bologa, ...
The Journal of steroid biochemistry and molecular biology 127 (3-5), 358-366, 2011
2202011
The system can't perform the operation now. Try again later.
Articles 1–20